Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

New study helps explain how endometriosis causes pain (opens in a new tab)

medicalxpress.com · 2026-09-28

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 2 supported
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Every claim we could check holds up. Two of five claims match the study. This overall rating is based only on the claims we could check. Three claims the study doesn't address.

  • 2 supported
  • 3 not covered
Open claim evidence
3
Source paper

Source layer

The 2 papers the story cites

Source study separated from background citations.

The research anchor for the report.

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5Not coveredNew Yale research may help explain why some patients with a small number of endometriosis growths experience debilitating pain while others with more widespread disease have no symptoms.View evidenceHide evidence

Why this verdict

The abstract-level profile supports a hedged idea that lesion gene-expression and inflammatory-pathway differences may help explain symptomatic versus asymptomatic endometriosis. However, the specific lead framing about a small number of growths causing debilitating pain while more widespread disease is asymptomatic is not directly evidenced in the supplied abstract profile; lesion number or disease extent is not analyzed there.

1

Study evidence

A case–control comparison of lesion transcriptomes identified 890 genes differentially expressed between symptomatic and asymptomatic endometriosis samples.890 differentially expressed genes

“We performed RNA sequencing of 27 formalin-fixed, paraffin-embedded peritoneal biopsies from 9 symptomatic (Sx) and 10 asymptomatic (ASx) subjects.”
2

Study evidence

GSEA / GO pathway enrichment of differential-expression results identified 22 enriched GO pathways, of which 7 were immunologic.22 enriched GO pathways; 7 immunologic

“Gene Set Enrichment Analysis identified functional enrichment in 22 gene ontology (GO) pathways, of which 7 represented immunologic pathways.”
Claim 2 of 5Not coveredProtein measurements confirmed increased inflammatory molecules in the biopsies, and elevated IL16 was linked to pain severity.View evidenceHide evidence

Why this verdict

The IL16 part is supported at the gene-expression level: IL16 expression correlated with pain severity in a mild-versus-severe symptomatic stratification. But the claim that protein measurements confirmed increased inflammatory molecules is not present in the abstract-level profile, which describes RNA expression and computational pathway/network findings rather than protein confirmation.

1

Study evidence

IL16 expression correlated with pain severity among symptomatic cases after stratification into mild versus severe pain based on clinical criteria.

“Of all molecules identified as associated with pain, IL16 expression also correlated with symptom severity when cases were stratified into mild vs. severe pain based on clinical criteria.”
2

Study evidence

A case–control comparison of lesion transcriptomes identified 890 genes differentially expressed between symptomatic and asymptomatic endometriosis samples.890 differentially expressed genes

“We performed RNA sequencing of 27 formalin-fixed, paraffin-embedded peritoneal biopsies from 9 symptomatic (Sx) and 10 asymptomatic (ASx) subjects.”
Claim 3 of 5Not coveredThe researchers hope the findings could lead to new treatments that directly target the mechanisms driving endometriosis pain, and they say more research is needed to test whether blocking IL16 reduces pain.View evidenceHide evidence

Why this verdict

The broad speculative framing—that the findings nominate candidate mechanisms and possible future therapeutic targets—is consistent with the profile. But the specific statement that researchers plan to test whether IL16-blocking drugs reduce pain is not documented in the supplied abstract-level paper profile, so that specific future-treatment claim cannot be verified at this depth.

1

Study evidence

A case–control comparison of lesion transcriptomes identified 890 genes differentially expressed between symptomatic and asymptomatic endometriosis samples.890 differentially expressed genes

“We performed RNA sequencing of 27 formalin-fixed, paraffin-embedded peritoneal biopsies from 9 symptomatic (Sx) and 10 asymptomatic (ASx) subjects.”
2

Study evidence

IL16 expression correlated with pain severity among symptomatic cases after stratification into mild versus severe pain based on clinical criteria.

“Of all molecules identified as associated with pain, IL16 expression also correlated with symptom severity when cases were stratified into mild vs. severe pain based on clinical criteria.”
Claim 4 of 5SupportedResearchers studied biopsies from patients with symptomatic or asymptomatic endometriosis and found genetic differences that distinguish painful from nonpainful cases.View evidenceHide evidence

As statednine symptomatic patients and 10 asymptomatic patients

Why this verdict

The profile reports RNA-seq of 27 FFPE peritoneal biopsies from 9 symptomatic and 10 asymptomatic subjects and a differential-expression comparison distinguishing symptomatic from asymptomatic samples. The story’s phrase “genetic differences” is imprecise if read as DNA-level variants; the paper evidence is transcriptomic/gene-expression differences.

1

Study evidence

A case–control comparison of lesion transcriptomes identified 890 genes differentially expressed between symptomatic and asymptomatic endometriosis samples.890 differentially expressed genes

“We performed RNA sequencing of 27 formalin-fixed, paraffin-embedded peritoneal biopsies from 9 symptomatic (Sx) and 10 asymptomatic (ASx) subjects.”
Claim 5 of 5SupportedRNA sequencing identified almost 900 genes expressed differently between symptomatic and asymptomatic disease, with many differences involving inflammation-related genes.View evidenceHide evidence

As statedalmost 900 genes

Why this verdict

The profile reports 890 differentially expressed genes between symptomatic and asymptomatic samples, with inflammatory/immunologic signals highlighted by top genes, GSEA, and WGCNA. “Almost 900 genes” and inflammation-related differences are consistent with the abstract-level evidence.

1

Study evidence

A case–control comparison of lesion transcriptomes identified 890 genes differentially expressed between symptomatic and asymptomatic endometriosis samples.890 differentially expressed genes

“We performed RNA sequencing of 27 formalin-fixed, paraffin-embedded peritoneal biopsies from 9 symptomatic (Sx) and 10 asymptomatic (ASx) subjects.”
2

Study evidence

GSEA / GO pathway enrichment of differential-expression results identified 22 enriched GO pathways, of which 7 were immunologic.22 enriched GO pathways; 7 immunologic

“Gene Set Enrichment Analysis identified functional enrichment in 22 gene ontology (GO) pathways, of which 7 represented immunologic pathways.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • FFPE-derived RNA can have variable quality and may affect transcript quantification.

    This technical limitation is in the paper profile but is not mentioned in the story caveats.

    From Case–control-like transcriptome comparison of FFPE peritoneal biopsies; WGCNA co-expression network analysis with module

  • Potential clinical and lesion heterogeneity, including possible non-independence from multiple biopsies per subject and unclear covariate adjustment, may confound comparisons.

    The story does not discuss subject-level heterogeneity, multiple biopsies per subject, or adjustment for possible confounders.

    From Case–control-like transcriptome comparison of FFPE peritoneal biopsies; GSEA / GO pathway enrichment and WGCNA on RNA-se

  • The supplied abstract profile does not report independent validation or orthogonal protein confirmation of the inflammatory/pathway findings.

    The story states that protein measurements confirmed increased inflammatory molecules, but that confirmation is not present in the supplied abstract-level profile.

    From Case–control-like transcriptome comparison of FFPE peritoneal biopsies; GSEA / GO pathway enrichment and WGCNA on RNA-se

6 things the story did carry across
  • Primary study design: case-control-like RNA-seq comparison of FFPE peritoneal endometriosis biopsies from symptomatic versus asymptomatic subjects, with 27 biopsies from 19 subjects total.
  • Main transcriptomic finding: 890 genes were differentially expressed between symptomatic and asymptomatic endometriosis samples.
  • Inflammatory/immunologic pathway involvement: top genes, GSEA, and WGCNA highlighted immunologic/inflammatory signals associated with symptomaticity.
  • IL16 evidence: IL16 expression, not necessarily protein level, correlated with pain severity after symptomatic cases were stratified into mild versus severe pain.
  • The paper evidence is associative/ex vivo and does not establish that IL16, inflammatory pathways, or gene-expression changes cause pain.
  • Relatively small sample size limits power and generalizability, especially for the IL16 severity stratification.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

4

Evidence read

study summary

Lead result

ex vivo human

1Lead resultex vivo humanDetermine whether gene-expression differences in endometriotic peritoneal lesions distinguish symptomatic (pain) from asymptomatic endometriosis.Case–control-like transcriptome comparison of FFPE peritoneal biopsiesExpand

In plain English

RNA sequencing of FFPE peritoneal biopsies from symptomatic and asymptomatic endometriosis subjects identified broad transcriptomic differences: 890 genes were differentially expressed between symptomatic (Sx) and asymptomatic (ASx) samples, with enriched signals in inflammatory, cell-adhesion, and neuromodulatory genes. Pathway and network analyses (GSEA, WGCNA) highlighted immunologic/inflammatory pathways and co-expression modules associated with symptomaticity, and IL16 expression correlated with pain severity when cases were stratified by clinical criteria.

Key findings

  • A case–control comparison of lesion transcriptomes identified 890 genes differentially expressed between symptomatic and asymptomatic endometriosis samples.890 differentially expressed genes
  • Top differentially expressed genes implicated inflammatory signaling, cell adhesion, and neuromodulation (examples reported: IL16, IL17RA, JAK3, SMPD3, RELT; OLFML1, CDON, VCAN; SEMA6D, ADRA2C, SLC7A5).
“We performed RNA sequencing of 27 formalin-fixed, paraffin-embedded peritoneal biopsies from 9 symptomatic (Sx) and 10 asymptomatic (ASx) subjects.”
What this piece can’t prove
  • Relatively small sample size (27 biopsies from 19 subjects) limits generalizability and statistical power.
  • Use of FFPE tissue for RNA-seq can introduce technical variability in RNA quality and quantification.
  • Analyses are observational/ex vivo associations from lesion tissue and do not establish causal relationships between gene expression and pain.

1 further detail could not be confirmed from the summary.

2in silicoIdentify biological pathways/modules (e.g., immunologic/inflammatory) associated with symptomaticity using enrichment and network approaches.GSEA / GO pathway enrichment and WGCNA on RNA-seq differential expressionExpand

In plain English

Gene-set and network-level analyses of transcriptomes from peritoneal biopsies (RNA-seq of 27 FFPE samples from symptomatic and asymptomatic subjects) identified pathway-level differences between symptomatic and asymptomatic endometriosis. GSEA/GO enrichment returned 22 enriched GO pathways, seven of which were immunologic; co-expression network analysis (WGCNA) identified modules correlated with symptomaticity, including an immune/inflammatory-enriched module.

Key findings

  • GSEA / GO pathway enrichment of differential-expression results identified 22 enriched GO pathways, of which 7 were immunologic.22 enriched GO pathways; 7 immunologic
  • Weighted gene co-expression network analysis (WGCNA) identified 11 co-expression modules significantly correlated with symptomaticity, including one module strongly enriched for immunologic/inflammatory functions.11 modules correlated with symptomaticity; one module strongly enriched for immunologic/inflammatory functions
“Gene Set Enrichment Analysis identified functional enrichment in 22 gene ontology (GO) pathways, of which 7 represented immunologic pathways.”
What this piece can’t prove
  • Sample size is modest (27 biopsies from 9 symptomatic and 10 asymptomatic subjects) and the abstract does not clarify whether multiple biopsies per subject were independent or how subject-level effects were accounted for.
  • Enrichment and network findings are associative and do not establish causal roles for the implicated pathways in symptom generation.

2 further details could not be confirmed from the summary.

3in silicoIdentify biological pathways/modules (e.g., immunologic/inflammatory) associated with symptomaticity using enrichment and network approaches.WGCNA co-expression network analysis with module–trait correlation and functional enrichmentExpand

In plain English

Weighted Gene Correlation Network Analysis (WGCNA) of RNA-seq data from peritoneal biopsies identified 11 co-expression modules significantly correlated with symptomatic versus asymptomatic endometriosis; one of these modules was strongly enriched for immunologic/inflammatory functions.

Key findings

  • WGCNA identified 11 co-expression modules that were significantly correlated with symptomaticity (symptomatic vs asymptomatic endometriosis).11 modules
  • One of the modules correlated with symptomaticity was strongly enriched for immunologic/inflammatory functions (as determined by gene ontology enrichment).
“Weighted Gene Correlation Network Analysis (WGCNA) identified 11 co-expression modules significantly correlated with symptomaticity, including one module strongly enriched for immunologic/inflammatory functions.”
What this piece can’t prove
  • Relatively small sample set reported in abstract (27 biopsies from 19 subjects), which may limit statistical power and generalizability.

3 further details could not be confirmed from the summary.

4secondary dataTest whether a leading pain-associated gene signal (IL16) correlates with symptom severity (mild vs severe pain stratification).Stratified subgroup correlation (candidate-gene)Expand

In plain English

Among symptomatic endometriosis cases, higher IL16 gene expression was reported to correlate with greater pain severity after stratifying cases into mild versus severe pain using clinical criteria.

Key findings

  • IL16 expression correlated with pain severity among symptomatic cases after stratification into mild versus severe pain based on clinical criteria.
“Of all molecules identified as associated with pain, IL16 expression also correlated with symptom severity when cases were stratified into mild vs. severe pain based on clinical criteria.”
What this piece can’t prove
  • Small number of symptomatic cases in the cohort (reported n=9); per-stratum counts for mild vs severe not provided.
  • Unclear whether and how multiple comparisons were accounted for in this follow-up correlation.

1 further detail could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 23 candidate papers

Candidate

Author response for "Physics-informed machine learning for predicting temperature-dependent chemical properties"

2026 · Crossref

Source (opens in a new tab)

And 17 more candidates considered.